Análise da decisão de compra de medicamentos frente à existência de produtos substitutos: um estudo no município de Belo Horizonte, Brasil

e Sousa, Caissa Veloso; de Mesquita, Jose Marcos Carvalho; Lara, José Edson
November 2013
Revista Ciência & Saúde Coletiva;nov2013, Vol. 18 Issue 11, p3311
Academic Journal
The scope of this study is to identify the factors that influence the consumer's decision when buying medicine. Prior to the Generics Act (Lei dos Genéricos), consumers had at their disposal two product purchase options in the private market, namely buying a reference drug and a similar one. Generic drugs are part of a public policy which was intended to broaden access to medication by the general population at more accessible costs, while maintaining the same quality as the reference drug, as ensured by bioequivalence tests from the national health surveillance agency ANVISA. Nevertheless, a question arises as to whether the potential consumer knows the difference between generic, similar and reference drugs, especially when taking into account the decision at the moment of purchase. In order to fulfill the proposed objective, a survey was conducted with 403 residents in Belo Horizonte, Brazil. The data gathered was tabulated and analyzed using factor analysis and crosstab. The results made it possible to infer that there is a strong predisposition among consumers to accept the suggestions of the pharmacists and/or salesman, and a significant portion of the population is confused at the moment of purchase.


Related Articles

  • COMPARATIVE BIOEQUIVALENCE STUDY OF MELOXICAM DRUGS. Karieva, Ekut; Yunusova, KhÀLida // Medical & Health Science Journal;Apr2011, Vol. 5 Issue 1, p112 

    The governments of many countries strongly support the production and clinical use of generic medicinal products which are \"copies\" of patented drugs and can be marked at lower cost. At present time bioequivalence testing is regarded as a useful methodology to perform comparisons among...

  • BIOEQUIVALENCE STUDY OF ANTIMIGRAINE DRUG IN HEALTHY ADULT HUMAN SUBJECTS UNDER FED CONDITIONS. Kumar, Hemant; Majumder, Avijit; Sharma, Akanksha // Pharmacophore;Mar/Apr2014, Vol. 5 Issue 2, p287 

    Bioequivalence studies are the preliminary requirement for generic products to enter in the market. International regulatory authorities require that the final quality judgment of an oral dosage form be based on its in vitro dissolution profile and its in vivo bioavailability or bioequivalence...

  • Comparative pharmacokinetic and pharmacodynamic evaluation of branded and generic formulations of meloxicam in healthy male volunteers. Tacca, Mario Del; Pasqualetti, Giuseppe; Gori, Giovanni; Pepe, Pasquale; Paolo, Antonello Di; Lastella, Marianna; Negri, Ferdinando De; Blandizzi, Corrado // Therapeutics & Clinical Risk Management;2013, Vol. 9, p303 

    Purpose: The primary aim of the present study was to assess the pharmacokinetic bioequivalence between a generic formulation of meloxicam 15 mg tablets (Meloxicam Hexal) and its respective brand product (Mobic), in order to verify whether the generic product conforms to the regulatory standards...

  • Drug use issues and actions IN BRIEF.  // Formulary;Jul2001, Vol. 36 Issue 7, p542 

    Focuses on the cost effectiveness of converting gabapentin capsules to bioequivalent tablets in the United States. Interchange potential of tablets for capsules; Percentage of gabapentin prescription eligible for interchange; Advantages of gapabentin capsule-to-tablet therapeutic interchange;...

  • Influence of decision aids on patient preferences for anticoagulant therapy: a randomized trial. Holbrook, Anne; Labiris, Renée; Goldsmith, Charles H.; Ota, Kaede; Harb, Sandra; Sebaldt, Rolf J. // CMAJ: Canadian Medical Association Journal Supplement;5/22/2007, Vol. 176 Issue 11, p1583 

    Background: Decision aids have been shown to be useful in selected situations to assist patients in making treatment decisions. Important features such as the format of decision aids and their graphic presentation of data on benefits and harms of treatment options have not been well studied....

  • THEORIES, FACTS AND THE ANALYSIS OF CONSUMER CHOICE. Dacey, Raymond // Advances in Consumer Research;1975, Vol. 2 Issue 1, p671 

    This paper considers the role of information in a model of inductive learning and decision making. Specifically, conditions are given under which the classical Bayesian framework is maintained in the face of information which is similar to that provided by advertisers under the regulation of the...

  • NONMETRIC UNIDIMENSIONAL SCALING OF CONSUMER PREFERENCES FOR PROPOSED PRODUCT DESIGNS. Sewall, Murphy A. // Advances in Consumer Research;1978, Vol. 5 Issue 1, p22 

    Multidimensional scaling is an increasingly popular device for analyzing consumer preferences. However, in some instances a one dimensional scale may provide an adequate basis for decision-making. This paper describes a procedure for unidimensional scaling of rating data and presents empirical...

  • Difficult viewing.  // Marketing (00253650);3/3/2010, p12 

    The article presents the author's insights regarding consumer choice theory, specifically the work of Kahnemann, which reveals how raise in available choices make it harder for costumer to form a decision concerning a product.

  • Improving Inhaled Product Testing. Copley, Mark // Pharmaceutical Technology;Feb2013, Vol. 25 Issue 2, p34 

    The article discusses need for improvement in orally inhaled products (OIP) in vitro test data and in vivo behavior. It mentions that the improvement in OIP is needed for the successful implementation of quality by design (QbD), for reducing the costs of OIP development and in vitro...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics